Drug interactions between Miradon and nafcillin
| Results for the following 2 drugs: |
|---|
| Miradon (anisindione) |
| nafcillin |
Interactions between your selected drugs
nafcillin ↔ anisindione
Applies to:nafcillin and Miradon (anisindione)
MONITOR CLOSELY: Dicloxacillin and nafcillin may diminish the hypoprothrombinemic effect of warfarin. The exact mechanism of interaction is unknown but may involve induction of hepatic warfarin metabolism by these penicillins. There have been case reports of patients who developed warfarin resistance following dicloxacillin or high-dose nafcillin therapy, resulting in increased warfarin requirement. In one case report, a 29-year-old male on long-term, stable anticoagulant therapy developed resistance to warfarin while receiving IV nafcillin 12 gm/day. His prothrombin time (PT) fell from 20 to 25 seconds down to 14 to 17 seconds despite doubling of his warfarin dosage. The warfarin half-life was 11 hours during nafcillin therapy and 44 hours eight months after discontinuation of nafcillin. In a retrospective review of patients enrolled in an anticoagulant clinic, investigators identified seven patients who had been stabilized on their warfarin regimen for at least 2 weeks prior to starting dicloxacillin therapy. A decrease in PT occurred approximately 4 to 5 days following initiation of dicloxacillin. The mean number of days from the initiation of dicloxacillin to the lowest recorded PT was 11.4 and the mean number of days from the last day of dicloxacillin therapy to the return of the PT to baseline was 22. The mean of the baseline and lowest recorded PTs were 18.2 and 15.1 seconds, respectively, representing a 17% decrease. Five patients required supplemental doses and/or dosage increases of warfarin. Another study found that dicloxacillin treatment led to a mean decline in PT of 9.1% (range 2% to 24%) in seven patients stabilized on warfarin for at least 2 weeks. No data are available for other oral anticoagulants.
MANAGEMENT: Coagulation parameters should be monitored more closely during coadministration of warfarin with dicloxacillin or nafcillin and for several weeks after discontinuation of the antibiotic. The same precaution may be applicable during therapy with other oral anticoagulants.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
